Your Sorted CME/CE Activities

Talking PAH: A Live CME Webcast Series - Novel Therapies for Pulmonary Arterial Hypertension
AMA/ANCC/ACPE Activity
Pulmonary arterial hypertension (PAH) is a debilitating and progressive disease characterized by pulmonary artery vasoconstriction and vascular remodeling leading to elevation of pulmonary arterial pressures and pulmonary vascular resistance. Current PAH-specific therapies have significantly improved the outlook for patients by improving functional capacity, pulmonary hemodynamics and reducing hospitalization. PAH remains an incurable disease necessitating further research and treatment options. This webcast provides an update on novel advances in pharmacological therapy in PAH.

These live, interactive webcasts focus on several important aspects of PAH management including a discussion of clinical trial data on emerging therapeutics for the management of PAH; and a review of strategies to optimize outcomes for patients with PAH. To register, click on your preferred date and time. If you are unable to attend one of the live webcasts, you will be able to access the archived video here for credit
Review the activities and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.




David Badesch, MD, FACP, FCCP David Badesch, MD, FACP, FCCP
Professor of Medicine
Dept. of Pulmonary & Critical Care Medicine,
Director, Pulmonary Hypertension Center
University of Colorado
Mardi Gomberg Maitland, MD, MSc Mardi Gomberg Maitland, MD, MSc
Director of Pulmonary Hypertension
George Washington University School of Medicine and Health Sciences
  Marius Hoeper, MD Marius Hoeper, MD
Professor, Department of
Respiratory Medicine
Hannover Medical School
 Marc Humbert, MD, PhD Marc Humbert, MD, PhD
Professor of Medicine, University Paris-Saclay
Department of Respiratory Medicine, Hopital Bicetre
Vallerie Mclaughlin, MD Vallerie V. Mclaughlin, MD
Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine
Associate Chief Clinic Officer, Cardiovascular Service Line, UMMG
Associate Chief, Division of Cardiovascular Medicine
Director, Pulmonary Hypertension Program
Ronald Oudiz, MD, FACP, FACC, FCCP Ronald Oudiz, MD, FACP, FACC, FCCP
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
Lundquist Institute at Harbor-UCLA Medical Center
Aaron B. Waxman, MD, PhD Aaron B. Waxman, MD, PhD
Executive Director
Center for Pulmonary Heart Disease
   

20
Supported by an independent educational grant from Acceleron Pharma Inc.
Mini Module
7215
TalkingPAH_EBlastBanner(1150).gif
Pulmonology